BIO-TECHNE CORP (TECH)

US09073M1045 - Common Stock

74.69  -1.27 (-1.67%)

After market: 74.69 0 (0%)

News Image
13 hours ago - Bio-Techne Corporation

UPDATED: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS

/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) has recently achieved In Vitro Diagnostic Regulation (IVDR) certification for its R&D Systems Hematology...

News Image
a day ago - Bio-Techne Corporation

BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS

/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) has recently achieved In Vitro Diagnostic Regulation (IVDR) certification for its R&D Systems Hematology...

News Image
4 days ago - Bio-Techne Corporation

BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES

/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it will present at the following investor conferences: UBS Global Healthcare...

News Image
5 days ago - Bio-Techne Corporation

ScaleReady Announces multiple G-Rex® Grants have been awarded to leading investigators at the Baylor College of Medicine's Center for Cell and Gene Therapy

/PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf Manufacturing and Bio-Techne Corporation and CellReady, has awarded G-Rex Grants totaling...

News Image
7 days ago - Bio-Techne Corporation

LUNAPHORE COMET™ PLATFORM PAVES THE WAY FOR SPATIAL BIOLOGY ADOPTION IN CLINICAL RESEARCH

/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced the release of clinically relevant spatial biology data. The data was generated using...

News Image
13 days ago - Chartmill

What's going on in today's session: S&P500 movers

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Wednesday.

News Image
13 days ago - Chartmill

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Wednesday.

Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top S&P500 gainers and losers in today's session.

News Image
13 days ago - Chartmill

Which S&P500 stocks are gapping on Wednesday?

What's going on in today's session: S&P500 gap up and gap down stocks

News Image
13 days ago - Market News Video

S&P 500 Movers: SMCI, GRMN

News Image
13 days ago - Chartmill

Discover the top S&P500 movers in Wednesday's pre-market session and stay informed about market dynamics.

Before the US market kicks off on Wednesday, let's examine the pre-market session and unveil the notable performers among the S&P500 top gainers and losers.

News Image
13 days ago - Bio-Techne Corporation

BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS

/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the first quarter ended September 30, 2024. First Quarter FY2025...

News Image
13 days ago - Bio-Techne Corporation

BIO-TECHNE DECLARES DIVIDEND

/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter...

News Image
14 days ago - Bio-Techne Corporation

ScaleReady Announces a G-Rex® Grant has been awarded to Luminary Therapeutics

/PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf Manufacturing and Bio-Techne Corporation (NASDAQ: TECH), today announced that Luminary...

News Image
a month ago - Bio-Techne Corporation

BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS

/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, October 30, 2024,...

News Image
a month ago - Bio-Techne Corporation

ScaleReady announces a G-Rex® Grant has been awarded to LIfT Biosciences

/PRNewswire/ -- ScaleReady™, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady™, and LIfT BioSciences,...

News Image
a month ago - Bio-Techne Corporation

ScaleReady announces a G-Rex® Grant has been awarded to Dr. Eric Tran of the Earle A. Chiles Research Institute, a division of Providence Cancer Institute

/PRNewswire/ -- ScaleReady™, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady™, today announced that Eric...

News Image
a month ago - Bio-Techne Corporation

ScaleReady announces a G-Rex® Grant has been awarded to renowned cancer immunologist Dr. Christopher A. Klebanoff

/PRNewswire/ -- ScaleReady™, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady™, today announced that...

News Image
2 months ago - Bio-Techne Corporation

LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCH

/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that one of its spatial biology brands, Lunaphore, is partnering with Discovery Life...

News Image
2 months ago - Bio-Techne Corporation

BIO-TECHNE TO PRESENT AT NEUROSCIENCE 2024-THE SOCIETY FOR NEUROSCIENCE (SfN) ANNUAL MEETING

/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced it will showcase its portfolio of solutions advancing neuroscience research at the...

News Image
2 months ago - Market News Video

YieldBoost TECH To 11.2% Using Options

News Image
2 months ago - Bio-Techne Corporation

BIO-TECHNE ISSUES 2024 CORPORATE SUSTAINABILITY REPORT

/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today issued its 2024 Corporate Sustainability Report (CSR), detailing the continued progress advancing...

News Image
2 months ago - Bio-Techne Corporation

ScaleReady announces a G-Rex® Grant has been awarded to ImmunoScape

/PRNewswire/ -- ScaleReady™, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady™, today announced that...

News Image
2 months ago - Bio-Techne Corporation

ScaleReady announces a G-Rex® Grant has been awarded to Verismo Therapeutics

/PRNewswire/ -- ScaleReadyTM, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH), and CellReadyTM, today announced that it...

News Image
2 months ago - Verismo Therapeutics

Verismo Therapeutics Awarded a ScaleReady™ G-Rex® Grant

/PRNewswire/ -- Verismo Therapeutics, a clinical-stage CAR T company developing the novel KIR-CAR platform technology, today announced that it has been awarded...

News Image
2 months ago - Bio-Techne Corporation

ScaleReady and Bio-Techne Announce Optimal Closed System Cytokine Packaged for Single Step Use in Closed System G-Rex® Manufacture of CAR-T and TCR Therapies

/PRNewswire/ -- ScaleReady and Bio-Techne Corporation (NASDAQ: TECH) today announced the launch of the G-Rex optimized ProPakTM GMP Cytokines, ideally tailored...

News Image
3 months ago - Bio-Techne Corporation

ScaleReady announces the inaugural G-Rex® Grant has been awarded to Stanford Medicine Laboratory for Cell and Gene Medicine

/PRNewswire/ -- ScaleReady™, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady™, today announced that Dr....

News Image
3 months ago - Bio-Techne Corporation

BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES

/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer will present at the following...

News Image
3 months ago - Market News Video

Wednesday Sector Laggards: Healthcare, Materials

News Image
3 months ago - InvestorPlace

TECH Stock Earnings: Bio-Techne Meets EPS, Misses Revenue for Q4 2024

TECH stock results show that Bio-Techne met analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2024.

News Image
3 months ago - Bio-Techne Corporation

BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS

/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter ending June 30, 2024. Fourth Quarter FY2024...

News Image
3 months ago - Bio-Techne Corporation

BIO-TECHNE DECLARES DIVIDEND

/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter...

News Image
3 months ago - InvestorPlace

3 Genomics Stocks That May Transform Personalized Medicine

These are three of the best genomics stocks to buy for a lucrative entry into a specialized section of the biotech industry.

News Image
4 months ago - Bio-Techne Corporation

BIO-TECHNE ANNOUNCES STRATEGIC INVESTMENT IN SPEAR BIO

/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced its participation in Spear Bio's $45 million Series A funding round. Spear Bio will use...

News Image
4 months ago - Bio-Techne Corporation

BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2024 FINANCIAL RESULTS

/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, August 7, 2024, at...

News Image
4 months ago - InvestorPlace

7 Cheap Biotech Stocks With Major Upside Potential

While the broader healthcare sector enjoys permanent relevance, you can potentially maximize your upside with cheap biotech stocks.